TR199901904T2 - 3-piridil enantiyomerleri ve bunlarin analjezik olarak kullanilmasi. - Google Patents

3-piridil enantiyomerleri ve bunlarin analjezik olarak kullanilmasi.

Info

Publication number
TR199901904T2
TR199901904T2 TR1999/01904T TR9901904T TR199901904T2 TR 199901904 T2 TR199901904 T2 TR 199901904T2 TR 1999/01904 T TR1999/01904 T TR 1999/01904T TR 9901904 T TR9901904 T TR 9901904T TR 199901904 T2 TR199901904 T2 TR 199901904T2
Authority
TR
Turkey
Prior art keywords
formula
analgesics
enantiomers
pyridyl
relates
Prior art date
Application number
TR1999/01904T
Other languages
English (en)
Inventor
W. Holladay Mark
P. Arneric Stephen
Bai Hao
J. Dart Michael
Lin Nan-Horng
K. Lynch John
Sun Or Yat
B. Ryther Keith
P. Sullivan James
T. Wasicak James
P. Ehrlich Paul
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Publication of TR199901904T2 publication Critical patent/TR199901904T2/tr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/04—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Vascular Medicine (AREA)
  • Emergency Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Psychiatry (AREA)
  • Urology & Nephrology (AREA)
  • Rheumatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

FORMÜL (I).Bu bulus memelilerde ve yine bu kapsama giren insanlarda agrinin denetim altina alinmasina yönelik bir yöntemle ilgili olup, buna ihtiyaç duyan memeliye ya da hastaya formül (I) e özgü seçkin bilesiklerin ya da bunlarin farmasötik açidan geçerli bir tuzunun verilmesini içerir. Bulus ayrica, analjezik olarak yararli ve ayni zamanda nöronal hücre ölümünü önleyen ve antienflamatuvar olan formül (I) e özgü seçkin (R) ve (S) bilesikleriyle ilgilidir.
TR1999/01904T 1996-12-10 1997-12-10 3-piridil enantiyomerleri ve bunlarin analjezik olarak kullanilmasi. TR199901904T2 (tr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US76327896A 1996-12-10 1996-12-10
US3232196P 1996-12-10 1996-12-10

Publications (1)

Publication Number Publication Date
TR199901904T2 true TR199901904T2 (tr) 1999-10-21

Family

ID=26708255

Family Applications (1)

Application Number Title Priority Date Filing Date
TR1999/01904T TR199901904T2 (tr) 1996-12-10 1997-12-10 3-piridil enantiyomerleri ve bunlarin analjezik olarak kullanilmasi.

Country Status (21)

Country Link
EP (1) EP0950057B1 (tr)
JP (2) JP4272261B2 (tr)
KR (2) KR100422995B1 (tr)
CN (1) CN1125064C (tr)
AT (1) ATE227717T1 (tr)
AU (1) AU733881B2 (tr)
BG (1) BG64196B1 (tr)
BR (1) BR9714677A (tr)
CA (2) CA2698384C (tr)
DE (1) DE69717148T2 (tr)
DK (1) DK0950057T3 (tr)
ES (1) ES2189003T3 (tr)
HU (1) HUP0001110A3 (tr)
IL (1) IL130083A0 (tr)
NO (1) NO992705L (tr)
NZ (1) NZ335810A (tr)
PL (1) PL333920A1 (tr)
PT (1) PT950057E (tr)
SK (1) SK75999A3 (tr)
TR (1) TR199901904T2 (tr)
WO (1) WO1998025920A1 (tr)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2880699A (en) 1998-04-02 1999-10-25 R.J. Reynolds Tobacco Company Pharmaceutical compositions and methods for use
US6054451A (en) * 1998-04-21 2000-04-25 Algos Pharmaceutical Corporation Analgesic composition and method for alleviating pain
US6362371B1 (en) 1998-06-08 2002-03-26 Advanced Medicine, Inc. β2- adrenergic receptor agonists
US20010031771A1 (en) 1999-05-24 2001-10-18 Gary Maurice Dull Pharmaceutical compositions and methods for use
US6103911A (en) * 1999-06-15 2000-08-15 Abbott Laboratories Process for reduction of (2R)-4-oxoazetidinone-2-carboxylic acid
US6818787B2 (en) 2001-06-11 2004-11-16 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
US8048917B2 (en) 2005-04-06 2011-11-01 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
US7186855B2 (en) 2001-06-11 2007-03-06 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
WO2003097043A1 (en) * 2002-05-15 2003-11-27 Abbott Laboratories Treatment of neuropathic pain
EP1741709A1 (en) 2005-06-28 2007-01-10 Sanofi-Aventis Deutschland GmbH Heteroaryl-substituted amides comprising a saturated linker group, and their use as pharmaceuticals
US7579351B2 (en) 2005-12-09 2009-08-25 Hoffmann-La Roche Inc. Tricyclic amide derivatives
TW200800020A (en) * 2006-01-26 2008-01-01 Basf Ag Methods to use 3-pyridyl derivatives as pesticides
WO2008028903A2 (en) 2006-09-04 2008-03-13 Neurosearch A/S Pharmaceutical combinations of a nicotine receptor modulator and a cognitive enhancer
JP4939192B2 (ja) * 2006-12-05 2012-05-23 ユニ・チャーム株式会社 不織布、不織布の製造方法及び吸収性物品
DE102007058504A1 (de) 2007-12-05 2009-07-09 Acino Ag Transdermales therapeutisches System mit einem Gehalt an einem Modulator für nikotinische Acetylcholinrezeptoren (nAChR)
CN102216289A (zh) 2008-10-14 2011-10-12 塞扣吉尼克斯公司 烟碱乙酰胆碱受体配体及其用途
US8474529B2 (en) * 2009-04-09 2013-07-02 Regency Technologies Llc Control of concentric tubing direction
AR075988A1 (es) * 2009-04-09 2011-05-11 Lilly Co Eli Compuesto de piridiloxi - pirrolidina inhibidor de recaptacion de serotonina y norepinefrina, composicion farmaceutica que lo comprende y su uso para la manufactura de un medicamento util para el tratamiento de dolor cronico
JPWO2013002365A1 (ja) 2011-06-30 2015-02-23 東レ株式会社 止痒剤
EP2983666B1 (en) 2013-03-27 2019-10-09 Georgetown University 2-halo-5-alkynyl-pyridyl nicotinic ligands
WO2018226991A1 (en) 2017-06-07 2018-12-13 Shifamed Holdings, Llc Intravascular fluid movement devices, systems, and methods of use
CN111556763B (zh) 2017-11-13 2023-09-01 施菲姆德控股有限责任公司 血管内流体运动装置、系统
EP4085965A1 (en) 2018-02-01 2022-11-09 Shifamed Holdings, LLC Intravascular blood pumps and methods of use and manufacture
US11964145B2 (en) 2019-07-12 2024-04-23 Shifamed Holdings, Llc Intravascular blood pumps and methods of manufacture and use
US11654275B2 (en) 2019-07-22 2023-05-23 Shifamed Holdings, Llc Intravascular blood pumps with struts and methods of use and manufacture
EP4034192A4 (en) 2019-09-25 2023-11-29 Shifamed Holdings, LLC INTRAVASCULAR BLOOD PUMP SYSTEMS AND METHODS OF USE AND CONTROL THEREOF

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8301702D0 (en) * 1983-01-21 1983-02-23 Shell Int Research Azetidine compounds
US4902684A (en) * 1988-06-20 1990-02-20 E. R. Squibb & Sons, Inc. Benzazepine and benzothiazepine derivatives
US5068234A (en) * 1990-02-26 1991-11-26 Sterling Drug Inc. 3-arylcarbonyl-1-(c-attached-n-heteryl)-1h-indoles
IL107184A (en) * 1992-10-09 1997-08-14 Abbott Lab Heterocyclic ether compounds that enhance cognitive function
US5585388A (en) * 1995-04-07 1996-12-17 Sibia Neurosciences, Inc. Substituted pyridines useful as modulators of acetylcholine receptors
IL118279A (en) * 1995-06-07 2006-10-05 Abbott Lab Compounds 3 - Pyridyloxy (or Thio) Alkyl Heterocyclic Pharmaceutical Compositions Containing Them and Their Uses for Preparing Drugs to Control Synaptic Chemical Transmission
US5629325A (en) * 1996-06-06 1997-05-13 Abbott Laboratories 3-pyridyloxymethyl heterocyclic ether compounds useful in controlling chemical synaptic transmission

Also Published As

Publication number Publication date
KR100472154B1 (ko) 2005-02-21
NO992705D0 (no) 1999-06-03
KR100422995B1 (ko) 2004-03-12
SK75999A3 (en) 2000-05-16
PL333920A1 (en) 2000-01-31
KR20040004476A (ko) 2004-01-13
CA2273917C (en) 2010-05-25
CN1245496A (zh) 2000-02-23
AU5601098A (en) 1998-07-03
CA2698384C (en) 2012-05-01
DK0950057T3 (da) 2003-03-10
EP0950057B1 (en) 2002-11-13
JP2001504857A (ja) 2001-04-10
ATE227717T1 (de) 2002-11-15
DE69717148D1 (de) 2002-12-19
JP5364872B2 (ja) 2013-12-11
HUP0001110A3 (en) 2002-04-29
WO1998025920A1 (en) 1998-06-18
ES2189003T3 (es) 2003-07-01
JP4272261B2 (ja) 2009-06-03
CA2273917A1 (en) 1998-06-18
KR20000069399A (ko) 2000-11-25
IL130083A0 (en) 2000-02-29
CA2698384A1 (en) 1998-06-18
PT950057E (pt) 2003-04-30
BG64196B1 (bg) 2004-04-30
BR9714677A (pt) 2000-10-03
NO992705L (no) 1999-08-03
HUP0001110A2 (hu) 2001-04-28
NZ335810A (en) 2001-03-30
BG103556A (en) 2000-06-30
DE69717148T2 (de) 2003-10-02
JP2009143924A (ja) 2009-07-02
EP0950057A1 (en) 1999-10-20
AU733881B2 (en) 2001-05-31
CN1125064C (zh) 2003-10-22

Similar Documents

Publication Publication Date Title
TR199901904T2 (tr) 3-piridil enantiyomerleri ve bunlarin analjezik olarak kullanilmasi.
ATE244564T1 (de) Felbamat-derivate
TR200100047T2 (tr) Tiyobenzimidazol türevleri
TR199801315T2 (tr) X sendromunun tedavisi için bir ppar-alpha ve ppar-gamma antagonistinin kullanilmasi.
TR200001279T2 (tr) Poli (ADP-riboz) polimeraz ("PARP") inhibitörleri, nevral ve kardiyovasküler doku hasarının tedavisi için yöntemler ve farmasötik bileşimler.
DK0662958T3 (da) 1-(2-Oxoacetyl)piperidin-2-carboxylsyrederivater som multilægemiddelresistente cancercellesensibiliserende midler
BG105880A (en) Compounds useful as anti-inflammatory agents
DE60027564D1 (de) Tek-antagonisten
TR200101343T2 (tr) Kansere karşı kullanılan maddeler olarak alkinil-ikame edilmiş kinolin-2-on türevleri
BG106586A (en) Pyrazolopyramidines as therapeutic agents
PT705100E (pt) Guanidinas substituidas terapeuticas
TR199701535T1 (tr) Bis-1,2,4- triazolleri, kanserlerin tedavisi için bir ilaç üretilmesinde kullanimi.
IS5985A (is) Frumuviðloðunar-bælandi bólgu-eyðandi og ónæmisbælandi efnasambönd
TR199900157T2 (tr) Hücre proliferasyon inhibisyonu için ikame edilmis bisindolilmaleimidleri.
TR199900336T2 (tr) EAA antagonistleri olarak tetrahidrokinolin türevleri.
TR199902257T2 (tr) Tetrahidropirido bilesikleri
ATE386742T1 (de) Imidazonaphthyridine
ATE203519T1 (de) Chinolinderivate als antimalariamittel
DK1032556T3 (da) Farmaceutisk aktive forbindelser og anvendelsesfremgangsmåder
TR199900951T2 (tr) Gögüs kanserinin engellenmesi için yöntemler.
NO20031410D0 (no) Antitumorterapi innbefattende distamycinderivater
BR0208860A (pt) Uso de um derivado de dextrano catiÈnico, método para a proteção de um indivìduo contra o dano em órgãos com limitação de dose, e, método para a proteção de um indivìduo contra dano renal
TWI262791B (en) 6-methoxy-2-naphthylacetic acid prodrugs
TR200000753T2 (tr) Mukabil antifungal ajan için prodrog olarak tetrahidrofuran fosfat ve hidroksi esterleri.
PE61999A1 (es) Compuestos de tetrahidropiridina